Literature DB >> 12596448

[Phenotypic diagnosis of primary immunodeficiencies in Antioquia, Colombia, 1994-2002].

Carlos Julio Montoya1, Julieta Henao, Helí Salgado, María M Olivares, Juan A López, Claudia Rugeles, José Luis Franco, Julio Orrego, Diana M García, Pablo J Patiño.   

Abstract

Recurrent infections are a frequent cause of medical visits. They can be due to a heterogeneous group of dysfunctions that increase the susceptibility to pathogenic and opportunistic microorganisms, such as immunological deficiencies. To define an opportune rational treatment and to guide the molecular diagnosis of primary immunodeficiency diseases, we establish a program for the phenotypic diagnosis of these illnesses in Antioquia, Colombia, including clinical and laboratory evaluations of patients who present recurrent infections with abnormal evolution. Between August 1, 1994 and July 31, 2002, phenotypic diagnosis of primary immunodeficiency was made in 98 patients. Similar to data reported in the literature, antibody deficiencies were the most frequent (40.8%), followed by combined deficiencies (21.4%). This phenotypic characterization has allowed for appropriate treatments for each patient and, in some cases, functional and molecular studies that can lead to a definite molecular diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12596448

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  3 in total

1.  Population prevalence of diagnosed primary immunodeficiency diseases in the United States.

Authors:  J M Boyle; R H Buckley
Journal:  J Clin Immunol       Date:  2007-06-19       Impact factor: 8.317

2.  Disseminated bronchiectasis in an adult with common variable immunodeficiency.

Authors:  Andrés Felipe Zea-Vera; Olga Lucia Agudelo-Rojas
Journal:  Colomb Med (Cali)       Date:  2015-03-30

3.  Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia.

Authors:  William López-Quintero; Daniela Cleves; Jose David Gomez-Vasco; Paola Pérez; Jaime Patiño; Diego Medina-Valencia; Harry Pachajoa; Laura Torres-Canchala; Andres Vidal; Manuela Olaya
Journal:  World Allergy Organ J       Date:  2021-03-01       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.